Immunogenesis is tapping into ProBioGen’s manufacturing capabilities for its immuno-oncology lead candidate, as the potential treatment enters the clinic.
Nubilaria joins a wave of providers that is offering their services for free to researchers working on potential treatments for COVID-19, with its ACTide EDC web platform.